Table 1.
Category | Orlistat, n (%) (N=15) |
Lorcaserin, n (%) (N=27) |
Phentermine-topiramate, n (%) (N=26) |
Bupropion-naltrexone, n (%) (N=30) |
Liraglutide, n (%) (N=319) |
Semaglutide, n (%) (N=363) |
P valuea | |
Side effects | .04 | |||||||
|
No mention | 11 (73.3) | 27 (100) | 25 (96.2) | 25 (83.3) | 299 (93.7) | 337 (92.8) |
|
|
Positive | 0 (0) | 0 (0) | 0 (0) | 1 (3.3) | 2 (0.6) | 8 (2.2) |
|
|
Negative | 4 (26.7) | 0 (0) | 1 (3.8) | 4 (13.3) | 18 (5.6) | 18 (5.0) |
|
Efficacy | <.001 | |||||||
|
No mention | 9 (60.0) | 8 (29.6) | 15 (57.7) | 14 (46.7) | 62 (19.4) | 131 (36.1) |
|
|
Positive | 6 (40.0) | 19 (70.4) | 11 (42.3) | 13 (43.3) | 243 (76.2) | 230 (63.4) |
|
|
Negative | 0 (0) | 0 (0) | 0 (0) | 3 (10.0) | 14 (4.4) | 2 (0.6) |
|
Adherence | <.001 | |||||||
|
No mention | 14 (93.3) | 27 (100) | 26 (100) | 28 (93.3) | 288 (90.3) | 336 (92.6) |
|
|
Positive | 1 (6.7) | 0 (0) | 0 (0) | 0 (0) | 3 (0.9) | 21 (5.8) |
|
|
Negative | 0 (0) | 0 (0) | 0 (0) | 2 (6.7) | 28 (8.8) | 6 (1.7) |
|
Link | <.001 | |||||||
|
None | 6 (40.0) | 2 (7.4) | 4 (15.4) | 18 (60.0) | 93 (29.2) | 91 (25.1) |
|
|
Scientific | 1 (6.7) | 11 (40.7) | 5 (19.2) | 0 (0) | 196 (61.4) | 270 (74.4) |
|
|
Nonscientific | 8 (53.3) | 14 (51.9) | 17 (65.4) | 12 (40) | 30 (9.4) | 2 (0.6) |
|
aChi-square tests were conducted to assess statistical differences.